Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels

被引:0
|
作者
Laura Ibanez
Umber Dube
Benjamin Saef
John Budde
Kathleen Black
Alexandra Medvedeva
Jorge L. Del-Aguila
Albert A. Davis
Joel S. Perlmutter
Oscar Harari
Bruno A. Benitez
Carlos Cruchaga
机构
[1] Washington University in Saint Louis,Department of Psychiatry, School of Medicine
[2] Washington University in Saint Louis,Hope Center Program on Protein Aggregation and Neurodegeneration
[3] Washington University in Saint Louis,Medical Scientist Training Program, School of Medicine
[4] Washington University in St Louis,Department of Neurology, School of Medicine
[5] Washington University in Saint Louis,Department of Medicine, School of Medicine
来源
BMC Neurology | / 17卷
关键词
Parkinson disease; Genetics; Age at onset; Biomarkers; Polygenic risk score;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Alpha-synuclein spreading in Parkinson's disease
    Recasens, Ariadna
    Dehay, Benjamin
    [J]. FRONTIERS IN NEUROANATOMY, 2014, 8
  • [32] Peripheral Alpha-Synuclein and Parkinson's Disease
    Olanow, C. Warren
    Wakeman, Dustin R.
    Kordower, Jeffrey H.
    [J]. MOVEMENT DISORDERS, 2014, 29 (08) : 963 - 966
  • [33] Alpha-Synuclein and Familial Parkinson's Disease
    Pankratz, Nathan
    Nichols, William C.
    Elsaesser, Veronika E.
    Pauciulo, Michael W.
    Marek, Diane K.
    Halter, Cheryl A.
    Wojcieszek, Joanne
    Rudolph, Alice
    Pfeiffer, Ronald F.
    Foroud, Tatiana
    [J]. MOVEMENT DISORDERS, 2009, 24 (08) : 1125 - 1131
  • [34] Alpha-Synuclein Aggregation in Parkinson's Disease
    Srinivasan, E.
    Chandrasekhar, G.
    Chandrasekar, P.
    Anbarasu, K.
    Vickram, A. S.
    Karunakaran, Rohini
    Rajasekaran, R.
    Srikumar, P. S.
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [35] Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson's disease
    Shu, Hao
    Zhang, Pengcheng
    Gu, Lihua
    [J]. ACTA NEUROLOGICA BELGICA, 2024, 124 (03) : 831 - 842
  • [36] Longitudinal alpha-synuclein in cerebrospinal fluid in early Parkinson's disease, prodromal PD and healthy controls
    Mollenhauer, B.
    Caspell-Garcia, C.
    Coffey, C.
    Taylor, P.
    Singleton, A.
    Shaw, L.
    Trojanowski, J.
    Frasier, M.
    Simuni, T.
    Siderowf, A.
    Marek, K.
    Galasko, D.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S399 - S400
  • [37] Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson's Disease
    Menendez-Gonzalez, Manuel
    Padilla-Zambrano, Huber S.
    Tomas-Zapico, Cristina
    Fernandez Garcia, Benjamin
    [J]. BRAIN SCIENCES, 2018, 8 (04):
  • [38] Alpha-synuclein levels and dimerization in erythrocytes of Parkinson's disease patients
    Papagiannakis, N.
    Koros, C.
    Stamelou, M.
    Simitsi, A. M.
    Maniati, M.
    Antonelou, R.
    Papadimitriou, D.
    Dermentzaki, G.
    Moraitou, M.
    Michelakakis, H.
    Stefanis, L.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S205 - S205
  • [39] AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson's disease diagnosis
    Zhao, Hongli
    Zhao, Jue
    Hou, Jiapeng
    Wang, Siqing
    Ding, Yu
    Lu, Boxun
    Wang, Jian
    [J]. PROTEIN & CELL, 2017, 8 (09) : 696 - 700
  • [40] Cerebrospinal fluid α-synuclein levels in Parkinson's disease - changed or unchanged?
    Zetterberg, H.
    Petzold, M.
    Magdalinou, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (03) : 365 - 367